1-Methylamino-1-(3,4-methylenedioxyphenyl)propane

Source: Wikipedia, the free encyclopedia.
1-Methylamino-1-(3,4-methylenedioxyphenyl)propane
Clinical data
ATC code
  • none
Identifiers
  • 1-(1,3-Benzodioxol-5-yl)-N-methylpropan-1-amine
JSmol)
  • CNC(CC)C1=CC2=C(C=C1)OCO2
  • InChI=1S/C11H15NO2/c1-3-9(12-2)8-4-5-10-11(6-8)14-7-13-10/h4-6,9,12H,3,7H2,1-2H3 ☒N
  • Key:NLINVDHEDVEOMJ-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

1-Methylamino-1-(3,4-methylenedioxyphenyl)propane or M-ALPHA is an

EMCDDA new drug monitoring service.[1] It was described by Alexander Shulgin as similar in action to its demethylated homologue, ALPHA
, but with roughly twice the duration and twice the potency.

See also

References

  1. ^ "EMCDDA Annual Report 2010" (PDF). Archived from the original (PDF) on 2012-03-14. Retrieved 2011-10-10.


drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=1-Methylamino-1-(3,4-methylenedioxyphenyl)propane&oldid=1211279967"